MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1

被引:39
|
作者
Yang, Cheng-Liang [1 ,2 ]
Zheng, Xiao-Li [2 ]
Ye, Ke [2 ]
Ge, Hong [2 ]
Sun, Ya-Nan [2 ]
Lu, Yu-Fei [2 ]
Fan, Qing-Xia [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Canc Hosp, Henan Canc Hosp, Dept Radiat Oncol, Zhengzhou, Henan, Peoples R China
关键词
Non-small cell lung cancer; MicroRNA-183; MTA1; gene; Epithelial-mesenchymal transition; Invasion; Migration; EXPRESSION PROFILE; PROGNOSTIC MARKER; UP-REGULATION; ADENOCARCINOMA; INVASION; NSCLC; INHIBITION; BIOMARKERS; MIGRATION; DIAGNOSIS;
D O I
10.1159/000488412
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Backgrounds/Aims: MicroRNAs (miRs) often contribute to the progression of non-small cell lung cancer (NSCLC) via regulation of mRNAs that are involved in lung homeostasis. We conducted a study aimed at exploring the roles of miR-183 in the proliferation, epithelial-mesenchymal transition (EMT), invasion and migration of human NSCLC cells via targeting MTA1. Methods: NSCLC and adjacent normal tissues were collected from 194 patients with NSCLC. Positive expression of MTA1 protein was detected by immunohistochemistry. The highest levels of expression of miR-183 were detected using RT-qPCR in SPC-A-1 cells, which were selected and assigned to the following groups: blank, negative control (NC), miR-183 mimic, miR-183 inhibitor, siRNA-MTA1, and miR-183 inhibitor + siRNA-MTA1. The expression of miR-183 and the mRNA and protein expression of MTA1, E-cadherin, Vimentin, Snail, PCNA, Bax and Bcl-2 in tissues and transfected cells were measured using RT-qPCR and western blot analysis. Cell proliferation, apoptosis, migration and invasion were evaluated by CCK-8, flow cytometry, scratch tests and Transwell assays. Tumor xenografts were conducted in nude mice to determine tumor growth. Results: SPC-A-1 cells with the highest levels of miR-183 expression were selected. Compared with adjacent normal tissues, the expression of miR-183 and the mRNA and protein expression of E-cadherin and Bax were decreased in NSCLC tissues, while mRNA and protein expression of MTA1, Vimentin, snail, PCNA and Bcl-2 were increased. MiR-183 was over-expressed in the miR-183 mimic group and under-expressed in the miR-183 inhibitor and miR-183 inhibitor + siRNA-MTA1 groups. In the miR-183 mimic and siRNA-MTA1 groups, the mRNA and protein expression of E-cadherin and Bax, as well as cell apoptosis, were enhanced, while the expression levels of MTA1, Vimentin, snail, PCNA and Bcl-2 mRNA and protein, cell proliferation, migration, invasion and tumor growth were reduced relative to the blank and NC groups. The miR-183 inhibitor group exhibited an opposite trend. Conclusion: Our study indicates that miR-183 down-regulates MTA1 to inhibit the proliferation, EMT, migration and invasion of human NSCLC cells. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:93 / 106
页数:14
相关论文
共 50 条
  • [1] MTA1 expression correlates significantly with cigarette smoke in non-small cell lung cancer
    Xu, Lei
    Mao, Xiao-yun
    Fan, Chui-feng
    Zheng, Hua-chuan
    VIRCHOWS ARCHIV, 2011, 459 (04) : 415 - 422
  • [2] MTA1 expression correlates significantly with cigarette smoke in non-small cell lung cancer
    Lei Xu
    Xiao-yun Mao
    Chui-feng Fan
    Hua-chuan Zheng
    Virchows Archiv, 2011, 459 : 415 - 422
  • [3] TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN
    Shen, Hua
    Guan, Dan
    Shen, Jianxin
    Wang, Min
    Chen, Xiaofeng
    Xu, Tongpeng
    Liu, Lianke
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 77 : 1 - 6
  • [4] Down-Regulation of MiR-30c Promotes the Invasion of Non-Small Cell Lung Cancer by Targeting MTA1
    Xia, Yang
    Chen, Qiyou
    Zhong, Zhaopeng
    Xu, Caihua
    Wu, Chen
    Liu, Bin
    Chen, Yijiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2013, 32 (02) : 476 - 485
  • [5] Testin is a tumor suppressor in non-small cell lung cancer
    Wang, Ming
    Wang, Qian
    Peng, Wen-Jia
    Hu, Jun-Feng
    Wang, Zu-Yi
    Liu, Hao
    Huang, Li-Nian
    ONCOLOGY REPORTS, 2017, 37 (02) : 1027 - 1035
  • [6] MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1
    Xiao, Ling
    Zhou, Hui
    Li, Xiang-Ping
    Chen, Juan
    Fang, Chao
    Mao, Chen-Xue
    Cui, Jia-Jia
    Zhang, Wei
    Zhou, Hong-Hao
    Yin, Ji-Ye
    Liu, Zhao-Qian
    ONCOTARGET, 2016, 7 (26) : 40038 - 40046
  • [7] MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1
    Ding, X.
    Yang, Y.
    Sun, Y.
    Xu, W.
    Su, B.
    Zhou, X.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (05): : 546 - 552
  • [8] MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1
    X. Ding
    Y. Yang
    Y. Sun
    W. Xu
    B. Su
    X. Zhou
    Clinical and Translational Oncology, 2017, 19 : 546 - 552
  • [9] MicroRNA-140's inhibition on the cell migration and invasion of non-small cell lung cancer by down-regulating Smad3 expression
    Han, P.
    Wang, X-H.
    Han, Y-F.
    Chen, G-M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (21) : 9471 - 9479
  • [10] Genetic alterations of tumor suppressor ING1 in human non-small cell lung cancer
    Luo, Zhi-Gang
    Tang, Hao
    Li, Bing
    Zhu, Zhi
    Ni, Can-Rung
    Zhu, Ming-Hua
    ONCOLOGY REPORTS, 2011, 25 (04) : 1073 - 1081